SecBot SecBot
8-K ·Filed Oct 2, 2026

QNCX

Quince Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed25d 3h ago SEC0001193125-26-411260
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor the outcome of the October 6 Special Meeting — approval of the proposals will trigger the board refresh and potential dilution from Series C conversion and warrant exercise. The Definitive Proxy Statement filed August 25, 2026 contains the full terms of the proposals.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+5d ⚠ clustered
QNCX ▲ +8.66% at T+5d
NEUTRAL call +8.66% · α vs SPY +7.50% · entry $29.20 → $31.73
Next anchor: T+20d in 3d
Latest observation: T+15 -1.43% FF3 residual α
Entry = T+0 close
Oct 2, 2026
via day close
T+1d
-3.77%
call -3.77% · α -4.44%
$28.10
settled 22d ago
T+5d
+8.66%
call +8.66% · α +7.50%
$31.73
settled 18d ago
T+20d
Pending
in 3d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Three directors (June Bray, David Lamond, Christopher Senner) tendered conditional resignations effective after the October 6, 2026 Special Meeting, contingent on stockholder approval of proposals related to Series C Preferred Stock conversion, warrant exercise, and an authorized share increase. Four new directors (Bonuccelli, Patterson, Valentine, Wise) were conditionally appointed to take effect at the same time. The resignations are not due to any disagreement with the company, and the board committee composition will be refreshed accordingly.

Key Facts

  • Three directors (June Bray, David Lamond, Christopher Senner) tendered conditional resignations effective after the October 6, 2026 Special Meeting.
  • Resignations are contingent on stockholder approval of the Conversion Proposal, Minimum Price Proposal, and Authorized Shares Proposal.
  • Four new directors (Catherine Bonuccelli, Leone Patterson, James Valentine, Drayton Wise) were conditionally appointed effective at the same time.
  • The resignations were not the result of any disagreement with the company on operations, policies, or practices.
  • The authorized share count would increase from 250,000,000 to 275,000,000 if the Authorized Shares Proposal is approved.

Financial Impact

No financial figures disclosed; the filing is a governance restructuring tied to a pending stockholder vote on share issuance and authorized share increase.

Risk Factors

  • Stockholder vote on October 6 may not pass, leaving the board in its current composition.
  • Approval of the proposals could lead to significant dilution from Series C Preferred Stock conversion and warrant exercise.

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-411260
Document: 0001193125-26-411260-index-headers.html0001193125-26-411260
Document: 0001193125-26-411260-index.html0001193125-26-411260
Document: 0001193125-26-411260.txt0001193125-26-411260
12 reports for QNCX
Performance horizon
67% Hit rate @ T+5 2 of 3 directional calls Went positive at some point 3 of 3 best @ T+20▲ +10.28%Sep 4, 2026
Filters
Rows
Reports for QNCX — sortable, filterable
TypeNow
Oct 9, 2026
18d ago
8-K
BULLISH ★ 7/10
$31.73 $32.03▲ +0.95%▲ +2.91%$31.38 (−1.10%)
Oct 2, 2026
25d ago
DEFA14A
NEUTRAL ★ 5/10
$29.20 $31.73▲ +8.66%▲ +7.50%$31.38 (+7.47%)
Oct 2, 2026
25d ago
8-K
NEUTRAL ★ 3/10
$29.20 $31.73▲ +8.66%▲ +7.50%$31.38 (+7.47%)
Sep 4, 2026
7w ago
8-K
BEARISH ★ 8/10
$31.32 $28.59▲ +8.72%▲ +7.51%$31.38 (−0.19%)
Aug 25, 2026
9w ago
EFFECT
BEARISH ★ 5/10
$30.93 $32.11▼ −3.82%▼ −4.35%$31.38 (−1.45%)
Aug 14, 2026
10w ago
8-K
NEUTRAL ★ 5/10
$31.34awaiting T+5—$31.38 (+0.13%)
Aug 14, 2026
10w ago
Press Release
BULLISH ★ 6/10
$31.34awaiting T+5—$31.38 (+0.13%)
Aug 5, 2026
11w ago
S-3/A
NEUTRAL ★ 3/10
$28.88 $31.26▲ +8.24%▲ +7.89%$31.38 (+8.66%)
Jun 11, 2026
19w ago
3
NEUTRAL ★ 2/10
$0.9337 $0.9276▼ −0.65%▼ −1.01%$31.38 (+3260.82%)
May 18, 2026
23w ago
8-K
MIXED ★ 7/10
$19.90 $24.00▲ +20.60%▲ +18.99%$31.38 (+57.69%)
Showing 10 of 12

US Market Status

Market Open — Closes in 5h 6m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 2, 2026